Allergic rhinitis in children

Journal of Paediatrics and Child Health

Volumn 48, Issue 4, 2012, Pages 302-310

  Turner, Paul J ^a   Kemp, Andrew S ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

allergic rhinitis; child; rhinitis, diagnosis; rhinitis, therapy

Indexed keywords

ALLERGEN; AZELASTINE; BECLOMETASONE; BECLOMETASONE DIPROPIONATE; BUDESONIDE; CETIRIZINE; CETIRIZINE PLUS PSEUDOEPHEDRINE; CHLORPHENIRAMINE; CROMOGLYCATE DISODIUM; DECONGESTIVE AGENT; FEXOFENADINE; FLUTICASONE FUROATE; FLUTICASONE PROPIONATE; HISTAMINE; IMMUNOGLOBULIN E; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LEVOCABASTINE; LORATADINE; MOMETASONE FUROATE; NITRIC OXIDE; PROMETHAZINE; TELNASE; TRIAMCINOLONE; UNCLASSIFIED DRUG;

ALLERGIC RHINITIS; ASTHMA; BLOOD BRAIN BARRIER; BLURRED VISION; COGNITIVE DEFECT; DISEASE CLASSIFICATION; DISEASE CONTROL; DISEASE SEVERITY; DRUG BIOAVAILABILITY; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FOLLOW UP; HEALTH PRACTITIONER; HUMAN; INFLAMMATION; INSOMNIA; NASAL PRURITUS; NOSE AIRFLOW; NOSE OBSTRUCTION; PATIENT ASSESSMENT; PATIENT COMPLIANCE; POLLEN; PRESCRIPTION; PRICK TEST; PRIORITY JOURNAL; QUALITY OF LIFE; RESTLESSNESS; REVIEW; RHINORRHEA; SEIZURE; SKIN SENSITIZATION; SNEEZING; SOMNOLENCE; SUBLINGUAL IMMUNOTHERAPY; TREATMENT DURATION; XEROSTOMIA;

ADOLESCENT; CHILD; HUMANS; RHINITIS, ALLERGIC, SEASONAL;

EID: 84859565276     PISSN: 10344810     EISSN: 14401754     Source Type: Journal    
DOI: 10.1111/j.1440-1754.2010.01779.x     Document Type: Review

References (46)

1. Strachan D, Sibbald B, Weiland S, et al,. Worldwide variations in prevalence of symptoms of allergic rhinoconjunctivitis in children: the International Study of Asthma and Allergies in Childhood (ISAAC). Pediatr. Allergy Immunol. 1997; 8: 161-76. (Pubitemid 28127720)
2. Ait-Khaled N, Anderson HR, Asher MI, et al,. Worldwide time trends for symptoms of rhinitis and conjunctivitis: phase III of the International Study of Asthma and Allergies in Childhood. Pediatr. Allergy Immunol. 2007; 19: 110-24.
3. Hamouda S, Karila C, Connault T, Scheinmann P, de Blic J,. Allergic rhinitis in children with asthma: a questionnaire-based study. Clin. Exp. Allergy 2008; 38: 761-6. (Pubitemid 351550668)
4. Taramarcaz P, Gibson PG,. The effectiveness of intranasal corticosteroids in combined allergic rhinitis and asthma syndrome. Clin. Exp. Allergy 2004; 34: 1883-9. (Pubitemid 40023639)
5. Rachelefsky GS, Goldberg M, Katz RM, et al,. Sinus disease in children with respiratory allergy. J. Allergy Clin. Immunol. 1978; 61: 310-4. (Pubitemid 8335641)
6. Rachelefsky GS,. National guidelines needed to manage rhinitis and prevent complications. Ann. Allergy Asthma Immunol. 1999; 82: 296-305. (Pubitemid 29141092)
7. Yuksel H, Sogut A, Yilmaz H, Yilmaz O, Dinc G,. Sleep actigraphy evidence of improved sleep after treatment of allergic rhinitis. Ann. Allergy Asthma Immunol. 2009; 103: 290-4.
8. Vuurman EFPM, van Veggel LMA, Uiterwijk MMC, Leutner D, O'Hanlon JF,. Seasonal allergic rhinitis and antihistamine effects on children's learning. Ann. Allergy 1993; 71: 121-6. (Pubitemid 23245942)
9. Turner PJ, Foreman JC,. Hyperresponsiveness in the human nasal airway-new targets for the treatment of allergic airway disease. Mediators Inflamm. 1999; 8: 133-46. (Pubitemid 29332052)
10. Graft D, Aaronson D, Chervinsky P, et al,. A placebo- and active-controlled randomized trial of prophylactic treatment of seasonal allergic rhinitis with mometasone furoate aqueous nasal spray. J. Allergy Clin. Immunol. 1996; 98: s 724-31. (Pubitemid 26357237)
11. Turner P, Dear J, Scadding G, et al,. Role of kinins in seasonal allergic rhinitis: icatibant, a bradykinin B2 receptor antagonist, abolishes the hyperresponsiveness and nasal eosinophilia induced by antigen. J. Allergy Clin. Immunol. 2001; 107: 105-13. (Pubitemid 32105253)
12. Maruo K, Akaike T, Matsumura Y, et al,. Triggering of the vascular permeability reaction by activation of the Hageman factor-prekallikrein system by house dust mite proteinase. Biochim. Biophys. Acta. 1991; 1074: 62-8.
13. Scadding GK, Durham SR, Mirakian R, et al,. BSACI guidelines for the management of allergic and non-allergic rhinitis. Clin. Exp. Allergy 2008; 38: 19-42. (Pubitemid 350233401)
14. Ponsonby A-L, Dwyer T, Kemp A, Lim L, Cochrane J, Carmichael A,. The use of mutually exclusive categories for atopic sensitization: a contrasting effect for family size on house dust mite sensitization compared with ryegrass sensitization. Pediatr. Allergy Immunol. 2003; 14: 81-90. (Pubitemid 36644349)
15. Droste JH, Kerhof M, de Monchy JG, Schouten JP, Rijcken B,. Association of skin test reactivity, specific IgE, total IgE, and eosinophils with nasal symptoms in a community-based population study. The Dutch ECRHS Group. J. Allergy Clin. Immunol. 1996; 97: 922-32. (Pubitemid 26116985)
16. Gleeson M, Cripps AW, Hensley MJ, Wlodarczyk JH, Henry RL, Clancy RL,. A clinical evaluation in children of the Pharmacia ImmunoCAP system for inhalant allergens. Clin. Exp. Allergy 1996; 26: 697-702. (Pubitemid 26226584)
17. Sheikh A, Hurwitz B, Shehata Y,. House dust mite avoidance measures for perennial allergic rhinitis. Cochrane Database Syst. Rev. 2007; 1: CD001563.
18. O'Meara TJ, Sercombe JK, Morgan G, Reddel HK, Xuan W, Tovey ER,. The reduction of rhinitis symptoms by nasal filters during natural exposure to ragweed and grass pollen. Allergy 2005; 60: 529-32. (Pubitemid 40332983)
19. Egmar AC, Emenius G, Almqvist C, Wickman M,. Cat and dog allergen in mattresses and textile covered floors of homes which do or do not have pets, either in the past or currently. Pediatr. Allergy Immunol. 1998; 9: 31-5. (Pubitemid 28142354)
20. Gani F, Pozzi E, Crivellaro MA, et al,. The role of patient training in the management of seasonal allergic rhinitis and asthma: clinical implications. Allergy 2001; 56: 65-8. (Pubitemid 32099074)
21. Dykewicz MS, Fineman S, Skoner DP, et al,. Diagnosis and management of rhinitis: complete guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma, and Immunology. Ann. Allergy Asthma Immunol. 1998; 81: 478-518. (Pubitemid 28553778)
22. Salib RJ, Howarth PH,. Safety and tolerability profiles of intranasal antihistamines and intranasal corticosteroids in the treatment of allergic rhinitis. Drug. Saf. 2003; 26: 863-93. (Pubitemid 37188249)
23. Al Sayyad JJ, Fedorowicz Z, Alhashimi D, Jamal A,. Topical nasal steroids for intermittent and persistent allergic rhinitis in children. Cochrane Database Syst. Rev. 2007; 1: CD003163.
24. Weiner JM, Abramson MJ, Puy RM,. Intranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: systematic review of randomised controlled trials. BMJ 1998; 317: 1624-9. (Pubitemid 28554544)
25. Yanez A, Rodrigo GJ,. Intranasal corticosteroids versus topical H1 receptor antagonists for the treatment of allergic rhinitis: a systematic review with metaanalysis. Ann. Allergy Asthma Immunol. 2002; 89: 479-84. (Pubitemid 36187991)
26. Scadding G,. Optimal management of nasal congestion caused by allergic rhinitis in children: safety and efficacy of medical treatments. Paediatr. Drugs 2008; 10: 151-62. (Pubitemid 351629671)
27. Price D, Bond C, Bouchard J, et al,. International Primary Care Respiratory Group (IPCRG) Guidelines: management of allergic rhinitis. Prim. Care Respir. J. 2006; 15: 58-70. (Pubitemid 43155767)
28. Allen DB, Meltzer EO, Lemanske RF, et al,. No growth suppression in children treated with the maximum recommended dose of fluticasone propionate aqueous nasal spray for one year. Allergy Asthma Proc. 2002; 23: 407-13.
29. Schenkel EJ, Skoner DP, Bronsky EA, et al,. Absence of growth retardation in children with perennial allergic rhinitis after one year of treatment with mometasone furoate aqueous nasal spray. Pediatrics 2000; 105: E22.
30. Möller C, Ahlström H, Henricson KA, et al,. Safety of nasal budesonide in the long term treatment of children with perennial rhinitis. Clin. Exp. Allergy 2003; 33: 816-22. (Pubitemid 36760515)
31. Schad CA, Skoner DP,. Antihistamines in the pediatric population: achieving optimal outcomes when treating seasonal allergic rhinitis and chronic urticaria. Allergy Asthma Proc. 2008; 29: 7-13.
32. Simons FE,. Prospective, long-term safety evaluation of the H1-receptor antagonist cetirizine in very young children with atopic dermatitis. ETAC Study Group. Early Treatment of the Atopic Child. J. Allergy Clin. Immunol. 1999; 104: 433-40. (Pubitemid 29420443)
33. Ratner PH, Hampel F, Van Bavel J, et al,. Combination therapy with azelastine hydrochloride nasal spray and fluticasone propionate nasal spray in the treatment of patients with seasonal allergic rhinitis. Ann. Allergy Asthma Immunol. 2008; 100: 74-81.
34. Chen ST, Lu KH, Sun HL, Chang WT, Lue KH, Chou MC,. Randomized placebo-controlled trial comparing montelukast and cetirizine for treating perennial allergic rhinitis in children aged 2-6 yr. Pediatr. Allergy Immunol. 2006; 17: 49-54.
35. Di Lorenzo G, Pacor ML, Pellitteri ME, et al,. Randomized placebo-controlled trial comparing fluticasone aqueous nasal spray in mono-therapy, fluticasone plus cetirizine, fluticasone plus montelukast and cetirizine plus montelukast for seasonal allergic rhinitis. Clin. Exp. Allergy 2004; 34: 259-67. (Pubitemid 38315263)
36. Keskin O, Alyamac E, Tuncer A, Dogan C, Adalioglu G, Sekerel BE,. Do the leukotriene receptor antagonists work in children with grass pollen-induced allergic rhinitis? Pediatr. Allergy Immunol. 2006; 17: 259-68. (Pubitemid 43873585)
37. Rouse R,. Tighter restrictions planned for kids' cough meds. Medical Observer 2009 30 October. Available from:.
38. Calderon MA, Alves B, Jacobson M, Hurwitz B, Sheikh A, Durham S,. Allergen injection immunotherapy for seasonal allergic rhinitis. Cochrane Database Syst. Rev. 2007 (1); CD001936.
39. Roder E, Berger MY, de Groot H, van Wijk RG,. Immunotherapy in children and adolescents with allergic rhinoconjunctivitis: a systematic review. Pediatr. Allergy Immunol. 2008; 19: 197-207. (Pubitemid 351499173)
40. Rodriguez-Perez N, Ambriz-Moreno MJ, Canonica GW, Penagos M,. Frequency of acute systemic reactions in patients with allergic rhinitis and asthma treated with sublingual immunotherapy. Ann. Allergy Asthma Immunol. 2008; 101: 304-10.
41. Campbell DE,. Sublingual immunotherapy for children: are we there yet? Defining its role in clinical practice. Paediatr. Respir. Rev. 2009; 10: 69-74.
42. Wahn U, Tabar A, Kuna P, et al,. Efficacy and safety of 5-grass-pollen sublingual immunotherapy tablets in pediatric allergic rhinoconjunctivitis. J. Allergy Clin. Immunol. 2009; 123: 160-6.
43. Bufe A, Eberle P, Franke-Beckmann E, et al,. Safety and efficacy in children of an SQ-standardized grass allergen tablet for sublingual immunotherapy. J. Allergy Clin. Immunol. 2009; 123: 167-73.
44. Larenas-Linnemann D,. Sublingual immunotherapy in children: complete and updated review supporting evidence of effect. Curr. Opin. Allergy Clin. Immunol. 2009; 9: 168-76.
45. Marogna M, Tomassetti D, Bernasconi A, et al,. Preventive effects of sublingual immunotherapy in childhood: an open randomized controlled study. Ann. Allergy Asthma Immunol. 2008; 101: 206-11.
46. Jacobsen L, Niggemann B, Dreborg S, et al,. Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study. Allergy 2007; 62: 943-8. (Pubitemid 47037870)